tirzepatide regain weight after Stopping Obesity Medications:⁣, ⁣, NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD, explains a recent meta-analysis that showed projected return to baseline weight within 2 ✨ Tirzepatide patient — 6

Verma S, Goldenberg RM, Bhatt DL, Farkouh ME, Quan A, Teoh H, Connelly KA, Leiter LA, Friedrich JO

The SURMOUNT trial data tracked cardiovascular events across 6,600+ participants over 72 weeks and found no signal for increased serious arrhythmias, myocardial infarction, or sudden cardiac death compared to placebo

Shortages Prompt Reporting Deficiency The shortage of Ozempic and Monjaro has also been in the news, with diabetic patients upset that they can no longer access the medication needed for the treatment of their condition

Understanding the reasons for the denial can help individuals gather the necessary documentation and evidence to support their case